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Abstract
Increase of allergic conditions has occurred at the same pace with the Great 
Acceleration, which stands for the rapid growth rate of human activities upon earth 
from 1950s. Changes of environment and lifestyle along with escalating urbanization 
are acknowledged as the main underlying causes. Secondary (tertiary) prevention for 
better disease control has advanced considerably with innovations for oral immuno-
therapy and effective treatment of inflammation with corticosteroids, calcineurin in-
hibitors, and biological medications. Patients are less disabled than before. However, 
primary prevention has remained a dilemma. Factors predicting allergy and asthma 
risk have proven complex: Risk factors increase the risk, while protective factors 
counteract them. Interaction of human body with environmental biodiversity with 
micro- organisms and biogenic compounds as well as the central role of epigenetic 
adaptation in immune homeostasis have given new insight. Allergic diseases are good 
indicators of the twisted relation to environment. In various non- communicable dis-
eases, the protective mode of the immune system indicates low- grade inflammation 
without apparent cause. Giving microbes, pro- and prebiotics, has shown some prom-
ise in prevention and treatment. The real- world public health programme in Finland 
(2008– 2018) emphasized nature relatedness and protective factors for immunologi-
cal resilience, instead of avoidance. The nationwide action mitigated the allergy bur-
den, but in the lack of controls, primary preventive effect remains to be proven. The 
first results of controlled biodiversity interventions are promising. In the fast urban-
izing world, new approaches are called for allergy prevention, which also has a major 
cost saving potential.
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1  |  INTRODUC TION
From 1950s, the Great Acceleration of human activity coincides with 
the Anthropocene, a title suggested for a geological epoch of human 
impact on earth's ecosystems.1 Health and life expectancy have im-
proved in high income countries but much at the expense of environ-
ment. Population explosion, escalating urbanization, and overuse of 
natural resources have become the rule. The increase in emissions 
of greenhouse gases, global warming, massive extinction of species, 
and pollution are all part of the Anthropocene. We might be loos-
ing resilience as individuals and communities and face epidemics of 
both communicable (fast) and non- communicable (slow) diseases, 
with unpredictable outcomes.
Dawn of non- communicable diseases was evident in 1960s, 
when also increase of allergic diseases and asthma became obvious 
in most developed countries. Indeed, they are good indicators of 
the modern health hazards, for example, shown in the Finnish and 
Russian Karelia.2 In a relatively short period of time, after the sec-
ond world war, two geoclimatically and genetically close populations 
have developed contrasting immunological expression. In Russian 
Karelia, hay fever was rare, food allergies few and peanut allergy 
unknown. The contrast is neither explained by hereditary factors 
nor by air pollution or common chemicals but rather by changes in 
lifestyle and environment. Understanding the underlying reasons of 
this disparity would enable measures for prevention. Allergy is not 
an isolated case but concurrent with the increase of both type I and 
II diabetes, cardiovascular diseases, obesity, inflammatory bowel dis-
eases, even mental disorders and cancer.3
Resilience is defined as an ability to recover from or adjust to 
change or misfortune (Merriam- Webster Dictionary). Resilience 
is multidimensional; immunological, psychological, and societal 
aspects are all critical. Lack of it may be the main reason for the 
increasing burden of non- communicable diseases. Lack of the re-
silient immunity at individual or community level is also obvious 
during the current COVID- 19 pandemic. In general, resilience of the 
immune system means having the capacity to adapt to challenges 
by establishing, maintaining, and regulating an appropriate immune 
response. A resilient immune response is a healthy state: not too 
passive, not too active, and able to return to homeostasis. It is a fine 
balance between useful and harmful response, and no response at 
all. If resilience is lost, disease may follow.
Microbe- immune system interplay is decisive for resilience and 
the immune homeostasis. If the crosstalk is not versatile enough, 
dysregulation arises. Reduced contact to environmental microbial 
diversity is probably the main reason of the compromised immuno-
logical resilience of populations living in the modern, urban environ-
ment.4,5 In logistic regression models, risk factors of the disease in 
question are evaluated, but the models seldom identify protective 
factors as explanations or confounders6 (Figure 1).
In this paper, we present some of the recent insights of immuno-
logical resilience and biodiversity supporting health and preventing 
allergic diseases.
2  |  DIVERSIT Y OF LIFE
Biological diversity comes in two flavors. Structural biodiversity con-
sists of layers of life, starting from the diversity of ecosystems fol-
lowed by numerous species living within, and reaching the complex 
genetic and phenotypic variation between individuals. Biodiversity 
is also functional, indicating complex interactions between species 
and their biotic and abiotic environment. Microbial diversity has 
two dimensions, alpha and beta diversity. In any given sample, alpha 
diversity is a measurement of species richness (number of different 
taxa) and evenness (abundance of the taxa in question). Beta diversity 
a distance measure between samples and represents the composi-
tional dissimilarity or heterogeneity. Defining and measuring biodi-
versity accurately is, however, under constant debate.
In early 2021, the Global Biodiversity Information Facility, a da-
tabase collecting global species occurrence, listed 2,725,553 species 
Future research perspectives
• Knowledge of the determinants of immunological resil-
ience is a prerequisite for primary prevention.
• Controlled and real- world interventions to study both 
mechanisms and clinical effect of biodiversity.
• Functional capacity of the microbiome, what are the de-
cisive factors: richness, diversity, or composition?
• Transfer of microbiota from the environment to human 
body.
• Interaction of epigenetic markers with human or envi-
ronmental microbiota.
• Validation of the cellular effects of biogenic (volatile, or-
ganic) compounds in clinical setting.
Milestones
• Recognition of human body as a community of species 
(holobiont) and genomes (hologenome).
• Insight of epigenetic regulation of immune adaptation 
under continuous environmental pressure.
• Biodiversity hypothesis of health. Recognition biodiver-
sity as a major determinant of human health (WHO, The 
Convention on Biological Diversity 2015).
• Evidence- based nature/biodiversity loss, verified by 
a long- term follow- up (WWF, Living Planet Index 
1970– 2020).
• Concept of Planetary Health as the health of human 
civilization and the state of natural systems (The 
Rockefeller Foundation- Lancet Commission 2015).
• Paradigm shift in allergy prevention, from avoidance 
to immunological tolerance/resilience. Implementation 
of the first national programme for prevention (The 
Finnish Allergy Programme 2008– 2018)
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in 8 kingdoms of life (gbif.org). The majority of the species are still 
undescribed or not included to this database. Moreover, those king-
doms or domains representing the biodiversity that is invisible to 
human eyes, such as in bacteria, archaea, and microscopic fungi, do 
not have a clear definition of species. While most unknown species 
belong to these kingdoms, for example, insects are also poorly de-
scribed. The total number of eukaryotic species, that is, other king-
doms than bacteria, archaea, and viruses, vary somewhere between 
5 and 8.7 million.7,8 However, when accounting all forms of life, esti-
mates can reach up to 1 trillion species.9
2.1  |  Environmental microbial exposure
2.1.1  |  Urban vs. rural exposure
Microbial exposure and its diversity depend on the environment and 
living habits.10 Urban, man- made surface soil materials have poorer 
microbial communities compared to forest soil.11 Consequently, mi-
crobial communities on skin and in airways of children and adults 
tend to be poorer and more homogenous in urban than in rural in-
dividuals.4,12,13 This is also evident even in newborns and pets.14- 16 
This parallels with overall poverty of both macroscopic and micro-
scopic urban biodiversity (Figure 2).
Within a city, the green areas have a considerable impact on mi-
crobial diversity.17 Macroscopic diversity influences the diversity of 
microbial communities; species- poor grass fields hold less microbes 
than species- rich forested areas both in soil and air.18,19 Importantly, 
revegetation enriches soil microbial communities indicating that 
urban green spaces can facilitate beneficial microbial exposure.20 
Pollutants may shape plant and microbial communities21- 23 and are 
associated with negative functional potential of gut microbiota.24- 26 
Thus, exposure to beneficial environmental microbiota can be im-
proved by increasing vegetation and reducing pollution.
2.1.2  |  Indoor microbiota
In urban settings, the indoor microbial environment is largely com-
posed by human skin microbiota.27 People are exposed to their own 
microbes. Indoor microbial composition differs between rural and 
urban areas,28- 30 and between homes practicing farming or not.10,31 
When dirt was collected from doormats, urban dwellers carried in-
doors less microbiota than their rural counterparts.28 In urban areas, 
the summertime biodiversity of doormat dirt was at the same level 
as the wintertime minimum in rural areas.32 The high coverage of 
built environment around homes reduced the diversity of environ-
mental microbiota carried indoors, but already a backyard rich of 
plants can make a difference for individual microbiota.28,33
Lifestyle factors have a stronger effect on human microbiome than 
genetics as shown by studying identical twins.34 While microbial com-
munities differ between Western and indigenous populations such as 
tribes and hunter- gatherers,35 immigration, for example, from Thailand 
to United States causes a rather immediate westernization of gut 
microbiota.36 The analyses of microbiota differences between popu-
lations are confounded by a number of factors. Therefore, studying 
people in the same country but with contrasting lifestyles or environ-
ments is likely to give most relevant information.37
2.2  |  Biodiversity in health and disease
2.2.1  |  Human body as an ecosystem
Lynn Margulis used the concept Holobiont to describe the host (ani-
mal or plant) of being a community of species subject to continuous 
evolutionary pressure.38,39 Holobiont species are bionts, and hol-
ogenome is the combined genome of the bionts. The concept binds 
human health tightly with homeostasis of the holobiont (Figure 3).
Natural environment supports human health in a holistic man-
ner. Both visiting natural areas and living in green surroundings as-
sociates with physical, mental, and social health. Moreover, a natural 
living environment associates with reduced risk of mortality to any 
causes,40 also in urban areas.41
2.2.2  |  Infectious diseases
A meta- analysis showed that biodiversity reduced the prevalence of 
diseases caused either by micro- or macroparasites, consistently in 
F I G U R E  1  Human body is protected by two nested layers of 
biodiversity. They consist of micro- organisms residing in the living 
environment and on the external and internal surfaces of the 
body. The inner layer is dependent on the microbial colonization 
from the outer layer, from air, soil, and natural waters. In natural 
environment, humans also breathe biogenic (volatile, organic) 
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plants, wildlife, and humans.42,43 Especially vector- borne, generalist 
wildlife, and zoonotic pathogens are affected by changes to biodi-
versity.44 Interestingly, while diversity of parasites is also declining 
along other biodiversity,45 the risk of zoonoses increases. This may 
be due to the hampering of ecological mechanisms controlling pest 
abundance as well as the increased human contact with wildlife.
As biodiversity is lost from ecosystems, the persisting species 
tend to be those most likely to harbor and transmit pathogens; 
abundant, widespread, and resilient.43 Therefore, changing spe-
cies composition, rather than diversity per se, can affect disease 
risk.44 Moreover, even though the individual pathogen load may 
not change, the risk for an infection is higher in environments with 
low biodiversity.42,43,46 However, for some infectious diseases, mea-
sures to improve hygiene, increasing wealth, and targeted biomedi-
cal management can be more effective for disease prevention than 
biodiversity conservation.44,47
2.2.3  |  Non- communicable diseases
Biodiversity tends to support well- being and reduce the risk of 
asthma and allergic diseases.4,48 Visiting green environments 
has been associated with reduced stress and blood pressure.49 
Environmental diversity was associated with reduced risk of asthma 
in children,50 and increasing landscape- level biodiversity with re-
duced public hospital admissions due to respiratory diseases.51
All green is not, however, equal in terms of health outcomes. 
Living next to grassy areas or to coniferous forests has been associ-
ated even with an increased risk of asthma in urban children, possibly 
due to airborne biotic and abiotic contaminants.48,52 Even living some 
hundred meters from a green space does not guarantee exposure to 
rich environmental microbiota.53,54 Nevertheless, diverse vegetation 
in the immediate surroundings of homes, urban daycares, and schools 
have associated with reduced allergic sensitization4 and improved 
lung function55 suggesting that immediate exposure is of importance.
3  |  EPIGENETIC PL A STICIT Y FOR 
IMMUNOLOGIC AL RESILIENCE
Individuals with specific genotypes have different responses to the 
same exposure.56 This so- called flip- flop pattern results in poor 
replicability of associations between genotypes and disease, if envi-
ronmental exposure is not considered. Epigenetic modifications are 
emerging as promising mechanisms to understand the plasticity of 
gene- environment interaction.
F I G U R E  2  Urban, build environment, and changes in lifestyle (left) have increasingly disconnected children from the natural air, soil, and 
waters, the evolutionary home of Homo sapiens (right). Photos: M. Andersson, J. Haahtela, with permission
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Epigenetics refers to mechanisms that perpetuate alternative 
gene activity in the context of the same DNA sequence.57 Epigenetic 
modifications predispose health or disease by determining regions 
of the genome accessible to the transcription machinery. Resilience 
of the immune system depends on epigenetic adaptation through-
out life. DNA methylation, histone modifications, and small and long 
non- coding RNAs (lncRNAs) are hot topics in research.58 They play 
a central role in mediating environmental effects on health and dis-
ease (Figure 4).
3.1  |  Epigenome- wide studies (EWAS)
A genome- wide DNA methylation study of childhood asthma, in-
cluding age- matched controls, found 14 asthma associated CpG 
sites in whole blood which were replicable in independent study co-
horts.59 Altered DNA methylation profiles were found in eosinophils 
and cytotoxic T cells. Most of the modified CpG sites were identified 
at the age of 8 years, but none at birth emphasizing the postnatal 
environmental exposure in allergic disease.
Genome- wide DNA profiles have been investigated also in nasal 
epithelial samples.60- 62 In the PIAMA birth cohort, the EWAS anal-
ysis identified replicable DNA methylation profiles associated with 
asthma, rhinitis, and sensitization to aeroallergens.60 Cardenas 
et al61 reported that the differentially methylated regions in nasal 
epithelium associated with allergic asthma, Th2 signaling, eosino-
philia, and airway epithelial defense. Both studies concluded that 
the nasal epigenome may serve as a biomarker for asthma, rhinitis 
and airway inflammation.
3.2  |  Long non- coding RNAs
IncRNAs are an example of a rather new class of regulatory RNAs 
transcribed from DNA, but typically not translated into proteins.57 
lncRNAs are involved in both immune cell development and 
function.63- 66 Transcriptomics analyses of the Karelian Allergy co-
hort revealed depressed innate immunity signaling in Russian sub-
jects compared with their Finnish counterparts.2 Moreover, the 
gene- microbe network was richer and more diverse in the Russian 
subjects. Interestingly, a large part of the up- regulated genes in the 
Russian subjects were represented by lncRNAs, while one third of 
the down- regulated genes were immune- related. Indeed, lncRNAs 
may control host immune responses during microbial infection and 
Th2 differentiation.63,64,66 Differentially expressed IncRNAs may 
operate as mediators of both gene- environment and gene- microbe 
interaction, regulating responses not only against microbes but also 
against foreign proteins released, for example, by pollens.2
3.3  |  Interaction with microbiota
Epigenetic markers may distinguish patient groups, but little is 
known of their interaction with environmental or human micro-
biota, or with the immune system in general.67 Bacterial products 
such as peptidoglycans and short chain fatty acids (SCFAs) alter he-
matopoiesis by increasing neutrophils, macrophages, and dendritic 
cells.68 They modify immune reactivity of both myeloid69 and epi-
thelial70 cells, potentially through epigenetic reprogramming. A high- 
fiber diet71 or exposure to a biodiverse living environment, including 
F I G U R E  3  Human body as a 
community of species and genomes. 
Biotically diverse exposure calls for 
epigenetic signaling to modify and 
adapt immune regulation for resilience. 
Interruption may degrade or improve 
resilience. [In the middle, the drawing 
Vitruvian Man by Leonardo da Vinci, 
from the end of 15th century. Human 
body is an expression of the microcosm 






























Human body as an ecosystem
Community of species (holobiont) and genomes (hologenome)
*Risk for non-communicable diseases, 
  allergy and asthma among them
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soil exposure,72 promotes the outgrowth of intestinal bacteria. For 
example, members of the Bacteroidetes phylum generate from di-
etary fibers epigenetically active, immunomodulatory SCFAs, which 
inhibit histone modifications.71,73 This leads to hyperacetylation of 
intestinal macrophages and to the differentiation of Th1/Th17 ef-
fector T cells or Treg cells.
In mice on a high- fiber diet, SCFAs enhanced generation of den-
dritic cells, with an impaired ability to activate Th2 effector cells, thus 
protecting against allergic airway inflammation.71 Clostridia species 
able to generate SCFAs, associate with the resolution of food aller-
gies.74 These microbes also induce colonic Treg cells through histone 
H3 acetylation and protect against sensitization to food allergens.75
Acinetobacter lwoffii induces immune tolerance in both humans 
and animal models by activating Th1 and Treg differentiation, prob-
ably by epigenetic modifications.76 In support of this, Brand and 
coworkers demonstrated that prenatal administration of A. lwoffii 
prevented asthmatic phenotype in the progeny mediated by changes 
in H4 acetylation of IL4 and IFNg promoter regions.77
The gut microbiome produces diverse neuroendocrine molecules 
acting as modulators on gut- brain, gut- skin, or gut- lung interaction, in 
which epigenetic mechanisms like histone modifications and DNA 
methylation are involved. For example, gut microbiota may influence 
on cognition and Alzheimer disease through regulation of neural, en-
docrine, and immune pathways.78 One detail is skin itch, which is 
inhibited γ- aminobutyric acid (GABA) produced by gut Lactobacillus 
and Bifidobacterium species.79
Taken together, these results suggest that interventions which 
include epigenetically active microbes or microbial metabolites are 
useful both for primary and secondary allergy prevention.
The functionally most important epigenetic mechanisms are pre-
sented in Table 1.
4  |  CONTROLLED AND OPEN 
INTERVENTIONS
Direct, regular contact with soil or plants diversifies human mi-
crobiota,81 observed both on the skin82 and in the gut.33 For ex-
ample, children, in similar daycares, who spend several hours a 
day in natural environment, have more diverse skin microbiota 
than children with less outdoor activities. However, it is possible 
that environmental microbes are only transient members of the 
human microbiota,83 indicating that frequent contact with envi-
ronmental microbes may be needed for immuno- regulatory ef-
fects to arise.
4.1  |  Biodiversity interventions
There is an urgent need to test various exposure strategies, rang-
ing from active gardening and outdoor activities to indoor and per-
sonalized interventions. A key question is whether we should be 
F I G U R E  4  Epigenetic immune 
regulation is under a lifetime pressure 
























Environmental and microbial diversity
Urban development and changes in lifestyle 
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exposed to microbes by ingesting, inhaling, being in skin contact, 
or by all these means to promote balanced immune homeostasis,84 
(Figure 5).
Interventions can modify the living environment, change the liv-
ing habits, or target for both. Studies that enhance nature contacts 
and follow changes in the commensal microbiota and immune reg-
ulation are ongoing, but results have not been published.85 Urban 
citizens want the potential benefits of environmental microbial bio-
diversity, providing that the efficacy and safety of the nature- based 
solutions have been shown.86- 88
Composition of the microbial communities and their dynam-
ics of transfer in the introduced biodiversity elements are poorly 
known. When urban volunteers rubbed their hands in gardening 
soils materials for 20 s and washed hands in tap water, they attained 
markedly higher microbial diversity on the skin.89 In a 2- week in-
tervention, volunteers exposed themselves to a soil- like material, 
rich of microbes, or just continued life as usual.90 The exposure in-
creased the microbial diversity of both skin and stool. The change 
was associated with the expression of TGF- beta by peripheral 
blood mononuclear cells.
Epigenetic mechanism Function
DNA methylation and oxidation • DNA methylation of CpG dinucleotides is associated 
with transcription silencing.
• Methyl- CpG oxidation mediates active DNA 





• Various roles in transcription regulation.
Nucleosome remodeling • Chromatin changes control DNA accessibility 
and thus the binding of transcription regulators, 
transcription factors and transcription co- activators.
Non- coding RNAs (ncRNAs)
• Long non- coding RNAs (lncRNAs)
• Competing endogenous RNAs 
(ceRNAs)
• Enhancer RNAs (eRNAs)
• Circular RNAs (circRNAs)
• microRNAs (miRNAs)
• Divergent roles in cellular responses via RNA– DNA, 
RNA– RNA and RNA– protein interactions.
RNA modification and 
“epitranscriptome”
• Functional modifications in mRNAs and ncRNAs 
constitute the “epitranscriptome” representing a 
new layer of epigenetic regulation at the RNA level.
• The regulatory roles of RNA modifiers in innate 
immunity and inflammation are still poorly 
understood.
TA B L E  1  Epigenetic mechanisms and 
their proposed functions. The data are 
mostly based on the review of Q. Zhang 
and X. Cao80
F I G U R E  5  We connect to the 
environment with senses and activities, 
and host, what we breathe, eat, drink, 
and touch. Activities in biotically diverse 
environment together with unprocessed 
food provide human body with microbiota 
for immune regulation,84 (modified)
Acquiring and maintaining microbiota by breathing,
eating, drinking and touching
• Urban/rural surrounding
• Pet, farm animal contact
• Housing characteristics
• Diet, drinking water, milk
• Lifestyle, outdoor activity, nature contact
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4.2  |  Enriching daycare yards
Roslund et al91enriched daycare yards with vegetated boreal forest 
soil blocks, sod, peat blocks, and gardening soil for growing vegeta-
bles (Figure 6). The study had two control arms, one without biodi-
versity intervention and one with nature- oriented daycare. Within 
1 month, the diversity of skin microbiota as well as the abundance of 
Proteobacteria were increased in children attending the intervention 
daycare compared to children in the non- modified daycare. The in-
creased ratio between serum interleukins 10 and 17A indicated acti-
vation of immune regulatory pathways. Importantly, the increase of 
immunomodulatory cytokines and regulatory T cells was associated 
with a higher diversity of the skin Gammaproteobacteria.
5  |  THE FINNISH NATIONWIDE AC TION 
FOR PRE VENTION
In Finland (population ca. 5.5 million), several successful national 
public health programmes have been completed to control respira-
tory diseases.92The Asthma programme (1994‒ 2004) improved 
the management by treating asthma primarily as an inflammatory 
disease.93 For allergic conditions, there are no reports of coordinated 
action plans to mitigate the burden nationwide. The recent Allergy 
Programme (2008‒ 2018) was taken to emphasize prevention, tol-
erance, and nature relatedness94,95 (Table 2). The main aim was to 
transform the strategy from avoidance to tolerance/resilience and 
focus on allergy health, especially in children.96 Severe clinical mani-
festations were given special attention. A major educational effort 
both for healthcare professionals and lay public followed.
Indeed, revisiting the allergy paradigm and systematic education 
mitigated the burden of allergic diseases in the Finnish society.97,98 
As this real- world intervention lacked controls, the true impact of 
primary prevention remains to be verified. The Finnish experience is, 
nevertheless, different from the global trend of asthma and allergy, 
the burden of which has remained high or is even increasing.99- 101 
This indicates that the current prevention strategies are ineffective 
and new approaches are required.
5.1  |  Case food allergy
In the Finnish Allergy Programme, food allergy guidance and prac-
tices were changed with favorable results.102,103 The thinking was 
F I G U R E  6  In the biodiversity intervention, the daycare yards were enriched with vegetated boreal forest soil blocks, sod, peat blocks, 
and by gardening the soil for growing vegetables91
TA B L E  2  Practical advice to improve immunological resilience and treatment in the Finnish Allergy Programme (2008– 2018)97
Primary prevention
• Support breastfeeding, solid foods from 4 to 6 months
• Do not avoid environmental exposure unnecessarily (eg, foods, pets)
• Strengthen immunity by increasing connection to natural 
environment
• Strengthen immunity by regular physical exercise
• Strengthen immunity by healthy diet (eg, traditional Mediterranean 
or Baltic type)
• Use antibiotics with care. Majority of microbes are useful and 
support health
• Probiotic bacteria in fermented food or other preparations may 
strengthen immunity
• Do not smoke
Secondary (tertiary) prevention
• Promote regular physical exercise, especially in asthmatics
• Promote healthy diet (Mediterranean or Baltic type of diet improves 
asthma control)
• Consider use of fermented food or other preparations, including 
probiotic bacteria
• Consider allergen specific immunotherapy:
• Allergens as is (foods)
• Sublingual tablets or drops (eg, grass pollen, birch pollen, house 
dust mite)
• Subcutaneous injections
• Hit early and hit hard respiratory/skin inflammation; find 
maintenance treatment for long- term control
• Do not smoke.
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based on new knowledge of immunological tolerance. The diversity 
of foods given at 6 months of age seems to protect from develop-
ment of food allergies.104,105 Most societies have adapted recom-
mending use of solid foods at 4– 6 months of age. There is likely an 
effect of this on the gut microbiome, but more data are required. 
Interestingly, a recent study indicated that oral immunotherapy 
(OIT) in peanut allergic adults increased gut microbial diversity.106 
Thus, the gut microbiota seems to shape the host immune system 
and vice versa.
Dual allergen exposure hypothesis states that immunological tol-
erance to a food depends on early exposure through the gastrointes-
tinal tract whereas allergic sensitization is more likely, when foods 
expose the impaired skin barrier.107 Among infants already sensitized 
to peanut before 6 months of age, high- dose exposure to peanut re-
sulted in decreased rather than increased risk of peanut allergy.104 This 
finding has been repeated with several other foods among children 
with high risk for allergies.105 For tolerance induction, there may be 
a window open between 4 and 6 months of age.108 In a prospective 
study, exposure to wheat before the age of 6 months reduced occur-
rence of allergy as compared with children who were given wheat first 
after 7 months of age.109
Early childhood oral tolerance induction is feasible in children 
who have not yet developed true food allergy for peanut or egg.110 
Oral immunotherapy is also a promising therapy for food allergy in 
older children up to adolescence. Efficacy has been shown in milk, 
peanut, egg, and wheat allergy. There is still debate about the pro-
portion of patients reaching long- term immunological tolerance.111 
The immunological changes occurring during the OIT therapy are 
illustrated in Figure 7.
Atopic march is a cascade of atopic disease in childhood, gen-
erally with atopic eczema in early childhood predating other aller-
gic disorders later in childhood. However, only approximately 7% 
of children with any atopic disease manifestation follow this path 
during childhood.112
Genetic factors have a major role in atopic disposition. For ex-
ample, mutations in the gene coding for the protein filaggrin, linked 
to epidermal and mucosal homeostasis, predispose to eczema.113 
Children carrying the risk allele for mucosa- associated lymphoid tis-
sue lymphoma translocation gene (MALT1) had the highest risk for 
peanut allergy.114
The outcome is derived much from the microbiome and en-
vironmental factors.115 It is uncertain how much the microbial 
composition is affected primarily by the type 2 inflammatory 
response or is the immune deviation caused by a poorly devel-
oped microbiome? However, there is a clear association with both 
atopic eczema, food allergy and early life lung colonization with 
the microbiome.116
6  |  CONCLUDING REMARKS
6.1  |  Biodiversity sets limits to human existence
The terrestrial and aquatic ecosystems promote biomass pro-
duction, stability, and pollination success, produce raw material 
for processing and manufacturing, support water circulation and 
freshwater resources, ensure food and support agriculture, se-
questrate carbon from the atmosphere, prevent soil erosion, and 
provide a place for recreation. A long- term manipulative field ex-
periment in Germany showed that about 45% of different types of 
ecosystem processes were affected by plant species richness.117 
However, the positive biodiversity effect seems to result from sev-
eral mechanisms acting simultaneously, and functional diversity is 
even a stronger predictor of a healthy ecosystem than the struc-
tural one.118 Loss of biodiversity reduces ecosystem productivity 
and stability.119,120 Now, we are also increasingly aware of the ad-
verse health effects of nature/biodiversity loss, allergic diseases, 
and asthma as examples.
F I G U R E  7  The immunological 
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Human kind has evolved from natural environments, that is from 
soil and natural waters, but is increasingly affected by built environ-
ment and urban space. The fuel for immunological resilience is ex-
posure to biotically diverse life.5 Human interaction with macro- and 
microdiversity is decisive.121 Urban populations are short of natural 
experience, not only of exposure to micro- organisms but also to bio-
genic compounds.122,123 The total exposure is also called the exposome 
that can help predict biological responses of the organism to the envi-
ronment over time.124
Immunological resilience is dynamic and derived from exposure 
through life. The importance of diverse microbial exposure in early 
life to prevent allergy risk has been reported in both humans and 
mice.125,126 Children, who live on farms, are exposed to a greater vari-
ety of environmental micro- organisms and have a lower prevalence of 
asthma and allergic disorders than children in reference groups.10,37 In 
mouse models of allergic asthma, intranasal instillation of dust extracts 
from homes with high levels of endotoxins significantly inhibited air-
way hyperresponsiveness and eosinophilia.37 Furthermore, exposure 
of mice to microbially rich and diverse soil modified composition of 
the intestinal microbiota, increased anti- inflammatory signaling in the 
intestinal epithelium, and protected against experimentally induced 
allergic asthma.72 Skin and epithelial barrier has a constant crosstalk 
with the environment and dysfunctional barrier predisposes to various 
health risks.127
Resilience is central not only to individuals but to societies and 
populations by and large.128,129 It is strengthened by an environment 
of multiple options giving room for choices. This is called redundancy 
in the biodiversity discussion. If one option fails, the other may suc-
ceed. In a biological or psychological monoculture, the failure of 
one may mean a failure of all. Biodiversity denotes abundance and 
even waste instead of extreme effectiveness. Paradoxically, waste 
creates buffers, that is, resilience. If a population is homogenous 
in the lack of immunity against COVID- 19, it may face extinction. 
Unpredictable chaos is characteristic to nature. Order and efficacy 
are the dreams of man.
Prevention is always more cost- effective that medical treatment. 
World Allergy Organization published already in 2013 a position 
statement advocating a Global Allergy Plan to improve prevention 
and tolerance.130 The Finnish nationwide, real- world intervention, 
controlled biodiversity interventions, and recent data on environ-
mental epidemiology, microbiome, and epigenetics give credibility 
to the statement. Several initiatives for prevention are ongoing and 
new insights presented.131- 133 The next step should be systematic 
implementation studies. Digital transformation in health and care 
may speed up to obtain results.134
Avoidance of allergens causing severe symptoms will remain as 
good clinical practice but does not solve the public health problem. 
Probiotic bacteria protect somewhat against atopic eczema, but not 
generally against IgE- mediated allergies, respiratory outcomes in 
particular. There are still a number of unknown nutritional135 and mi-
crobial factors that play a role in building immunological tolerance. 
For example, rhinovirus infections are associated with exacerbations 
of asthma. However, early rhinovirus infections as well as certain 
other enterovirus infections have associated with decreased risk of 
IgE- mediated sensitization.136 In secondary (tertiary) prevention, 
allergen specific immunotherapy is effective, but not applicable at 
population level.
Along with allergy prevention, also measures for other chronic 
non- communicable diseases have been discussed for a good reason. 
For example, Nurminen and coworkers found recently that exposure 
to biodiverse agricultural environment in early life delays the onset 
of β- cell damaging process among genetically predisposed children 
and reduces the risk for type 1 diabetes.137 Local communities and 
citizens need guidance to consider both human health and the en-
vironment.138,139 The Finnish city of Lahti (120 000 inhabitants) is 
the Green Capital of European Union in 2021.140 The city is prepar-
ing an educational 10- year plan to implement the best practices of 
public health and environmental care in the spirit of Planetary Health, 
which interconnects human health and the health of the planet.141 
The UN Agenda 2030 promotes individual- , community- , and system- 
level resilience for population well- being to reach the Sustainable 
Development Goals (SDGs).142
6.2  |  Money talks
In 2011, the total value of global ecoservices was estimated $125– 145 
trillion. They contributed more than twice as much to human well- 
being than global gross domestic product (GDP).143 Furthermore, 
more than half of the world's total GDP is fundamentally dependent 
on ecosystem services.144 Their loss from 1997 to 2011 was worth 
of $4.3– 20.2 trillion per year.143 Only 0.19– 0.25% of global GDP is 
yearly invested to sustain biodiversity.145 This discrepancy makes no 
sense ecologically or economically. By protecting global biodiversity, 
we protect our health, general well- being, as well as our wallets.146 
Although the positive outcome of the Finnish allergy programme ini-
tiative was due to several factors, the cumulative, deferred savings 
of around €1,2 billion during the period from 2007 to 2018 tell of the 
potential of disease prevention in the health care.147
CONFLIC T OF INTERE S T
TH has received personal lecturing fees from GSK, Mundipharma, 
Orion Pharma, Sanofi, and MJM from GSK, Orion Pharma, outside of 
the submitted work. AS and HH are stakeholders and members of the 
board of Uute Scientific LtD which develops biodiversity- based inter-
ventions for the prevention of immune mediated diseases.
ORCID
Tari Haahtela  https://orcid.org/0000-0003-4757-2156 
Jenni Lehtimäki  https://orcid.org/0000-0001-7220-1985 
Lasse Ruokolainen  https://orcid.org/0000-0003-0951-9100 
R E FE R E N C E S
 1. Waters CN, Zalasiewicz J, Summerhayes C, et al. The anthro-
pocene is functionally and stratigraphically distinct from the 
Holocene. Science. 2016;351:aad2622.
    |  11HAAHTELA ET AL.
 2. Ruokolainen L, Fyhrquist N, Laatikainen T, et al. Immune- 
microbiota interaction in Finnish and Russian Karelia young 
people with high and low allergy prevalence. Clin Exp Allergy. 
2020;50:1148- 1158.
 3. von Hertzen L, Joensuu H, Haahtela T. Microbial deprivation, in-
flammation and cabcer. Cancer Metastasis Rev. 2011;30:211- 223.
 4. Hanski I, von Hertzen L, Fyhrquist N, et al. Environmental biodi-
versity, human microbiota, and allergy are interrelated. Proc Natl 
Acad Sci USA. 2012;109:8334- 8339.
 5. Haahtela T. A biodiversity hypothesis. Allergy. 2019;74:1445- 1456.
 6. Ruokolainen L, Lehtimäki J, Karkman A, Haahtela T, von Hertzen 
L, Fyhrquist N. Holistic view of health: two protective layers of 
biodiversity. Ann Zool Fennici. 2017;54:39- 49.
 7. Mora C, Tittensor DP, Adl S, Simpson AGB, Worm B. How 
many species are there on earth and in the ocean? PLoS Biol. 
2011;9(8):e1001127.
 8. Costello MJ, May RM, Stork NE. Can we name earth’s species be-
fore they go extinct? Science. 2013;339:413- 416.
 9. Locey KJ, Lennon JT. Scaling laws predict global microbial diver-
sity. PNAS. 2016;113:5970- 5975.
 10. Ege MJ, Mayer M, Normand AC, et al. Exposure to environ-
mental microorganisms and childhood asthma. N Engl J Med. 
2011;364:701- 709.
 11. Puhakka R, Rantala O, Roslund MI, Laitinen OH, Sinkkonen A. 
Greening daycare yards with biodiverse materials affords well- 
being, play and environmental relationships. Int J Environ Res Public 
Health. 2019;16:2948.
 12. Ruokolainen L, von Hertzen L, Fyhrquist N, et al. Green areas 
around homes reduce atopic sensitization in children. Allergy. 
2015;70:195- 202.
 13. Ruokolainen L, Paalanen L, Karkman A, et al. Significant disparities 
in allergy prevalence and microbiota between the young people in 
Finnish and Russian Karelia. Clin Exp Allergy. 2017;47:665- 674.
 14. Lehtimäki J, Karkman A, Laatikainen T, et al. Patterns in the skin 
microbiota differ in children and teenagers between rural and 
urban environments. Sci Rep. 2017;7:45651.
 15. Lehtimäki J, Thorsen J, Rasmussen MA, et al. Urbanized microbiota in 
infants, immune constitution and later risk of atopic diseases. J Allergy 
Clin Immunol. 2020. https://doi.org/10.1016/j.jaci.2020.12.621
 16. Lehtimäki J, Sinkko H, Hielm- Björkman A, Laatikainen T, 
Ruokolainen L, Lohi H. Simultaneous allergic traits in dogs and 
their owners are associated with living environment, lifestyle and 
microbial exposures. Sci Rep. 2020;10:21954.
 17. Mhuireach G, Johnson BR, Altrichter AE, et al. Urban greenness 
influences airborne bacterial community composition. Sci Tot 
Environ. 2016;571:680- 687.
 18. Baruch Z, Liddicoat C, Cando- Dumancela C, et al. Increased plant 
species richness associates with greater soil bacterial diversity in 
urban green spaces. Environ Res. 2020;196:110425.
 19. Mhuireach GÁ, Wilson H, Johnson BR. Urban aerobiomes are in-
fluenced by season, vegetation, and individual site characteristics. 
EcoHealth. 2020. https://doi.org/10.1007/s1039 3- 020- 01493 - w. 
[Epub ahead of print].
 20. Mills JG, Bissett A, Gellie NJC, et al. Revegetation of urban green 
space rewilds soil microbiotas with implications for human health 
and urban design. Restor Ecol. 2020;28:S322- S334.
 21. Belz R, Sinkkonen A. Low toxin doses change plant size distribu-
tion in dense populations – Glyphosate exposed Hordeum vulgare 
as a greenhouse case study. Environ Int. 2019;2019(132):105072.
 22. Parajuli A, Grönroos M, Kauppi S, et al. The abundance of health- 
associated bacteria is altered in PAH polluted soils – implications 
for health in urban areas? PLoS One. 2017;12:e0187852.
 23. Roslund MI, Grönroos M, Rantalainen A- L, et al. Half- lives of PAHs 
and temporal microbiota changes in commonly used urban land-
scaping materials. PeerJ. 2018;6:1- 27.
 24. Roslund MI, Rantala S, Oikarinen S, et al. Endocrine disruption 
and commensal bacteria alteration associated with gaseous and 
soil PAH contamination among daycare children. Environ Int. 
2019;130:104894.
 25. Fouladi F, Bailey MJ, Patterson WB, et al. Air pollution exposure is 
associated with the gut microbiome as revealed by shotgun metag-
enomic sequencing. Environ Int. 2020;138:105604.
 26. Vari HK, Roslund MI, Oikarinen S, et al. Associations between land 
use types, gaseous PAH levels in ambient air and endocrine signal-
ing predicted from gut bacterial metagenome among the elderly. 
Chemosphere. 2021;265:128965.
 27. Adams RI, Bateman AC, Bik HM, Meadow JF. Microbiota of the 
indoor environment: a meta- analysis. Microbiome. 2015;3:49.
 28. Parajuli A, Grönroos M, Siter N, et al. Urbanization reduces trans-
fer of diverse environmental microbiota indoors. Front Microbiol. 
2018;9:84.
 29. Gupta S, Hjelmsø MH, Lehtimäki J, et al. Environmental shaping of 
the bacterial and fungal community in infant bed dust and correla-
tions with the airway microbiota. Microbiome. 2020;8:115.
 30. Shan Y, Guo J, Fan W, et al. Modern urbanization has reshaped the 
bacterial microbiome profiles of house dust in domestic environ-
ments. World Allergy Organ J. 2020;13:100452.
 31. Kirjavainen PV, Karvonen AM, Adams RI, et al. Farm- like indoor 
microbiota in non- farm homes protects children from asthma de-
velopment. Nat Med. 2019;25:1089- 1095.
 32. Hui N, Parajuli A, Puhakka R, et al. Temporal variation in indoor 
transfer of dirt- associated environmental bacteria in agricultural 
and urban areas. Environ Int. 2019;132:105069.
 33. Parajuli A, Hui N, Puhakka R, et al. Yard vegetation is associated with 
gut microbiota composition. Sci Total Environ. 2020;713:136707.
 34. Rothschild D, Weissbrod O, Barkan E, et al. Environment domi-
nates over host genetics in shaping human gut microbiota. Nature. 
2018;555:210- 215.
 35. Sonnenburg ED, Sonnenburg JL. The ancestral and industrial-
ized gut microbiota and implications for human health. Nat Rev 
Microbiol. 2019;17:383- 390.
 36. Vangay P, Johnson AJ, Ward TL, et al. US immigration westernizes 
the human gut microbiome. Cell. 2018;175:962- 972.
 37. Stein MM, Hrusch CL, Gozdz J, et al. Innate immunity and 
asthma risk in amish and hutterite farm children. N Engl J Med. 
2016;375:411- 421.
 38. Margulis L, Fester R. Symbiosis as a source of evolutionary innova-
tion. Cambridge, MA: MIT Press; 1991. ISBN 9780262132695.
 39. Simon J- C, Marchesi JR, Mougel C, Selosse M- A. Host- microbiota 
interactions: from holobiont theory to analysis. Microbiome. 
2019;7:5.
 40. Rojas- Rueda D, Nieuwenhuijsen MJ, Gascon M, Perez- Leon D, 
Mudu P. Green spaces and mortality: a systematic review and 
meta- analysis of cohort studies. Lancet Planet Health. 2019;3. 
https://doi.org/10.1016/S2542 - 5196(19)30215 - 3
 41. Bauwelinck M, Casas L, Nawrot TS, et al. Residing in urban areas 
with higher green space is associated with lower mortality risk: a 
census- based cohort study with ten years of follow- up. Environ Int. 
2021;148:106365.
 42. Civitello DJ, Cohen J, Fatima H, et al. Biodiversity inhibits parasites: 
broad evidence for the dilution effect. PNAS. 2015;112:8667- 8671.
 43. Keesing F, Ostfeld RS. Is biodiversity good for your health? Science. 
2015;349:235- 236.
 44. Rohr JR, Civitello DJ, Halliday FW, et al. Towards common ground 
in the biodiversity– disease debate. Nat EcolEvol. 2020;4:24- 33.
 45. Carlson CJ, Burgio KR, Dougherty ER, et al. Parasite biodiversity 
faces extinction and redistribution in a changing climate. Sci Adv. 
2017;3:1- 12.
 46. Susi H, Laine A- L. Agricultural land use disrupts biodiversity me-
diation of virus infections in wild plant populations. New Phytol. 
12  |    HAAHTELA ET AL.
2020. https://doi.org/10.1111/nph.17156. [Epub ahead of 
print].
 47. Wood CL, McInturff A, Young HS, Kim D, Lafferty KD. Human 
infectious disease burdens decrease with urbanization 
but not with biodiversity. Philos Trans R Soc Lond B Biol Sci. 
2017;372:20160122.
 48. Aerts R, Honnay O, Van Nieuwenhuyse A. Biodiversity and human 
health: mechanisms and evidence of the positive health effects of 
diversity in nature and green spaces. Br Med Bull. 2018;127:5- 22.
 49. Lanki T, Siponen T, Ojala A, et al. Acute effects of visits to urban 
green environments on cardiovascular physiology in women: a 
field experiment. Environ Res. 2017;159:176- 185.
 50. Donovan GH, Gatziolis D, Longley I, Douwes J. Vegetation diver-
sity protects against childhood asthma: results from a large New 
Zealand birth cohort. Nature Plants. 2018;4:358- 364.
 51. Liddicoat C, Bi P, Waycott M, Glover J, Lowe AJ, Weinstein P. 
Landscape biodiversity correlates with respiratory health in 
Australia. J Environ Manage. 2018;206:113- 122.
 52. Parmes E, Pesce G, Sabel CE, et al. Influence of residential land 
cover on childhood allergic and respiratory symptoms and diseases: 
evidence from 9 European cohorts. Environ Res. 2020;183:108953.
 53. Uetake J, Tobo Y, Uji Y, et al. Seasonal changes of airborne bacte-
rial communities over Tokyo and influence of local meteorology. 
Front Microbiol. 2019;10:1572.
 54. Baruch Z, Liddicoat C, Cando- Dumancela C, et al. Increased plant 
species richness associates with greater soil bacterial diversity in 
urban green spaces. Environ Res. 2021;196:110425.
 55. Cavaleiro Rufo JC, Ribeiro AI, Paciência I, Delgado L, Moreira A. 
The influence of species richness in primary school surround-
ings on children lung function and allergic disease development. 
Pediatr Allergy Immunol. 2020;31:358- 363.
 56. Simpson A, John SL, Jury F, et al. Endotoxin exposure, CD14, and 
allergic disease: an interaction between genes and the environ-
ment. Am J Respir Crit Care Med. 2006;174:386- 392.
 57. Cavalli G, Heard E. Advances in epigenetics link genetics to the 
environment and disease. Nature. 2019;571:489- 499.
 58. Tost J. A translational perspective on epigenetics in allergic dis-
eases. J Allergy Clin Immunol. 2018;142:715- 726.
 59. Xu CJ, Soderhall C, Bustamante M, et al. DNA methylation in child-
hood asthma: an epigenome- wide meta- analysis. Lancet Respir 
Med. 2018;6:379- 388.
 60. Qi C, Jiang Y, Yang IV, et al. Nasal DNA methylation profiling of 
asthma and rhinitis. J Allergy Clin Immunol. 2020;145:1655- 1663.
 61. Cardenas A, Sordillo JE, Rifas- Shiman SL, et al. The nasal meth-
ylome as a biomarker of asthma and airway inflammation in chil-
dren. Nat Commun. 2019;2019(10):3095.
 62. Forno E, Wang T, Qi C, et al. DNA methylation in nasal epithelium, 
atopy, and atopic asthma in children: a genome- wide study. Lancet 
Respir Med. 2019;2019(7):336- 346.
 63. Atianand MK, Fitzgerald KA. Long non- coding RNAs and con-
trol of gene expression in the immune system. Trends Mol Med. 
2014;20:623- 631.
 64. Gibbons HR, Shaginurova G, Kim LC, Chapman N, Spurlock CF 3rd, 
Aune TM. Divergent lncRNA GATA3- AS1 regulates GATA3 tran-
scription in T- Helper 2 Cells. Front Immunol. 2018;9:2512.
 65. Heward JA, Lindsay MA. Long non- coding RNAs in the regulation 
of the immune response. Trends Immunol. 2014;35:408- 419.
 66. Zhang H, Nestor CE, Zhao S, et al. Profiling of human CD4+ T- cell 
subsets identifies the TH2- specific noncoding RNA GATA3- AS1. J 
Allergy Clin Immunol. 2013;132:1005- 1008.
 67. Woo V, Alenghat T. Host- microbiota interactions: epigenomic reg-
ulation. Curr Opin Immunol. 2017;44:52- 60.
 68. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. 
Recognition of peptidoglycan from the microbiota by Nod1 en-
hances systemic innate immunity. Nat Med. 2010;16:228- 231.
 69. Olszak T, An D, Zeissig S, et al. Microbial exposure during early 
life has persistent effects on natural killer T cell function. Science. 
2012;336:489- 493.
 70. Naik S, Larsen SB, Gomez NC, et al. Inflammatory memory 
sensitizes skin epithelial stem cells to tissue damage. Nature. 
2017;550:475- 480.
 71. Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota me-
tabolism of dietary fiber influences allergic airway disease and he-
matopoiesis. Nat Med. 2014;20:159- 166.
 72. Ottman N, Ruokolainen L, Suomalainen A, et al. Soil exposure 
modifies the gut microbiota and supports immune tolerance in a 
mouse model. J Allergy Clin Immunol. 2019;143:1198- 1206.
 73. Park J, Kim M, Kang SG, et al. Short- chain fatty acids induce both 
effector and regulatory T cells by suppression of histone deacety-
lases and regulation of the mTOR- S6K pathway. Mucosal Immunol. 
2015;8:80- 93.
 74. Bunyavanich S, Shen N, Grishin A, et al. Early- life gut microbiome 
composition and milk allergy resolution. J Allergy Clin Immunol. 
2016;138:1122- 1130.
 75. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe- derived 
butyrate induces the differentiation of colonic regulatory T cells. 
Nature. 2013;504:446- 450.
 76. Fyhrquist N, Ruokolainen L, Suomalainen A, et al. Acinetobacter 
species in the skin microbiota protect against allergic sensitization 
and inflammation. J Allergy Clin Immunol. 2014;134:1301- 1309.
 77. Brand S, Teich R, Dicke T, et al. Epigenetic regulation in murine off-
spring as a novel mechanism for transmaternal asthma protection 
induced by microbes. J Allergy Clin Immunol. 2011;128:618- 625.
 78. Nagu P, Parashar A, Behl T, Mehta V. Gut microbiota composi-
tion and epigenetic molecular changes connected to the patho-
genesis of Alzheimer's disease. J Mol Neurosci. 2021. https://doi.
org/10.1007/s1203 1- 021- 01829 - 3. [Epub ahead of print].
 79. Akiyama T, Iodi Carstens M, Carstens E. Transmitters and path-
ways mediating inhibition of spinal itch- signaling neurons by 
scratching and other counterstimuli. PLoS One. 2011;6:e22665.
 80. Zhang Q, Cao X. Epigenetic regulation of the innate immune re-
sponse to infection. Nat Rev Immunol. 2019;19:417- 432.
 81. Selway CA, Mills JG, Weinstein P, et al. Transfer of environmental 
microbes to the skin and respiratory tract of humans after urban 
green space. Environ Int. 2020;145:106084.
 82. Lehtimäki J, Laatikainen T, Karkman A, et al. Nature- oriented day-
care diversifies skin microbiota in children— No robust association 
with allergies. Pediatr Allergy Immunol. 2018;29:318- 321.
 83. Bateman A. The Dynamics of Microbial Transfer and Persistence 
on Human Skin. 2017.https://schol arsba nk.uoreg on.edu/xmlui/ 
handl e/1794/22709. Accessed September 12, 2019.
 84. von Hertzen L, Beutler B, Bienenstock J, et al. Helsinki alert of 
biodiversity and health. Ann Med. 2015;47:218- 225.
 85. Prescott SL, Hancock T, Bland J, et al. Eighth annual conference 
of inVIVO planetary health: from challenges to opportunities. Int J 
Environ Res Public Health. 2019;16:4302.
 86. Puhakka R, Valve R, Sinkkonen A. Older consumers’ perceptions of 
functional foods and nonedible health- enhancing innovations. Int 
J Consum Stu. 2018;42:111- 119.
 87. Puhakka R, Ollila SA, Valve R, Sinkkonen A. Consumer trust 
in a health- enhancing innovation – comparisons between 
Finland, Germany and the United Kingdom. J Int Consum Mark. 
2019;31:162- 176.
 88. Puhakka R, Haskins L, Jauho M, Grönroos M, Sinkkonen A. Factors 
affecting young adults’ willingness to try novel health- enhancing 
nature- based products. J Int Consum Mark. 2021:1- 18. https://doi.
org/10.1080/08961 530.2021.1873887
 89. Grönroos M, Parajuli A, Laitinen OH, et al. Short- term direct con-
tact with soil and plant materials leads to an immediate increase in 
diversity of skin microbiota. Microbiol Open. 2019;8:1- 13.
    |  13HAAHTELA ET AL.
 90. Nurminen N, Lin J, Grönroos M, et al. Nature- derived microbi-
ota exposure as a novel immunomodulatory approach. Future 
Microbiol. 2018;13:737- 744.
 91. Roslund M, Puhakka R, Grönroos M, et al. Biodiversity interven-
tion enhances immune regulation and health- associated commen-
sal microbiota among daycare children. Sci Adv. 2020;6:1- 10.
 92. Erhola M, Vasankari T, Jormanainen V, Toppila- Salmi S, Herrala J. 
Haahtela T.25 years of respiratory health in Finland. Lancet Respir 
Med. 2019;7. https://doi.org/10.1016/S2213 - 2600(19)30122 - 5
 93. Haahtela T, Herse F, Karjalainen J, et al. The Finnish experience to 
save asthma costs by improving care in 1987– 2013. J Allergy Clin 
Immunol. 2017;139:408- 414.
 94. Haahtela T, von Hertzen L, Mäkelä M, Hannuksela M, Allergy 
Programme Working Group. Finnish allergy programme 2008- 2018 
‒ time to act and change the course. Allergy. 2008;63(6):634- 645.
 95. von Hertzen LC, Savolainen J, Hannuksela M, et al. Scientific ratio-
nale for the Finnish allergy programme 2008– 2018: emphasis on 
prevention and endorsing tolerance. Allergy. 2009;64:678- 701.
 96. Pelkonen AS, Kuitunen M, Dunder T, et al. Allergy in children: 
practical recommendations of the Finnish allergy programme 
2008– 2018 for prevention, diagnosis, and treatment. Pediatr 
Allergy Immunol. 2012;23:103- 116.
 97. Haahtela T, Valovirta E, Bousquet J, Mäkelä M, the Allergy 
Programme Steering Group. The Finnish allergy programme 
2008‒ 2018 works. Eur Repir J. 2017;49(6):1700470.
 98. Haahtela T, Valovirta E, Saarinen K, et al. The Finnish allergy pro-
gram 2008- 2018: society- wide proactive program for change of 
management to mitigate allergy burden. J Allergy Clin Immunol. 
2021. https://doi.org/10.1016/j.jaci.2021.03.037. [Epub ahead of 
print].
 99. Global Initiative for Asthma (GINA): Global strategy for asthma 
management and prevention. Online Appendix. Updated 2020. 
www.ginas thma.org. Accessed December 28, 2020.
 100. Mattiuzzi C, Lippi G. Worldwide asthma epidemiology: insights 
from the global health data exchange database. Int Forum Allergy 
Rhinol. 2020;1:75- 80.
 101. Dierick BJH, van der Molen T, Flokstra- de Blok BMJ, et al. Burden 
and socioeconomics of asthma, allergic rhinitis, atopic derma-
titis and food allergy. Expert Rev Pharmacoecon Outcomes Res. 
2020;14:1- 17.
 102. Erkkola M, Saloheimo T, Hauta- Alus H, et al. Burden of allergy 
diets in Finnish day care reduced by change in practices. Allergy. 
2016;71:1453- 1460.
 103. Savolainen J, Mascialino B, Pensamo E, et al. Structured interven-
tion planincluding component- resolved diagnostics helps reduring 
the burden of food allergy among school- aged children. Pediatr 
Allergy Immunol. 2019;30:99- 106.
 104. Du Toit G, Roberts G, Sayre PH, et al. Randomized trial of pea-
nut consumption in infants at risk for peanut allergy. N Engl J Med. 
2015;372:803- 813.
 105. Perkin MR, Logan K, Bahnson HT, et al. Efficacy of the enquiring 
about tolerance (EAT) study among infants at high risk of develop-
ing food allergy. J Allergy Clin Immunol. 2019;144:1606- 1614.
 106. He Z, Gouri Vadali VL, Szabady RL, et al. Increased diversity of gut 
microbiota during active oral immunotherapy in peanut- allergic 
adults. Allergy. 2021;76:927- 930.
 107. Brough HA, Nadeau KC, Sindher SB, et al. Epicutaneous sensitiza-
tion in the development of food allergy: what is the evidence and 
how can this be prevented? Allergy. 2020;75:2185- 2205.
 108. Ierodiakonou D, Garcia- Larsen V, Logan A, et al. Timing of aller-
genic food introduction to the infant diet and risk of allergic or au-
toimmune disease: a systematic review and meta- analysis. JAMA. 
2016;316:1181- 1192.
 109. Poole JA, Barriga K, Donald YM, et al. Timing of initial expo-
sure to cereal grains and the risk of wheat allergy. Pediatrics. 
2006;117:2175- 2182.
 110. Krawiec M, Fisher HR, Du Toit G, Bahnson HT, Lack G. Overview 
of oral tolerance induction for prevention of food allergy— Where 
are we now? Allergy. 2021. https://doi.org/10.1111/all.14758. 
[Epub ahead of print].
 111. Eiwegger T, Hung L, San Diego KE, O'Mahony L, Upton J. 
Recent developments and highlights in food allergy. Allergy. 
2019;74:2355- 2367.
 112. Custovic A, Custovic D, Kljaić Bukvić B, Fontanella S, Haider S. 
Atopic phenotypes and their implication in the atopic march. 
Expert Rev Clin Immunol. 2020;16:873- 881.
 113. Clark H, Granell R, Curtin JA, et al. Differential associations of al-
lergic disease genetic variants with developmental profiles of ec-
zema, wheeze and rhinitis. Clin Exp Allergy. 2019;49:1475- 1486.
 114. Winters A, Bahnson HT, Ruczinski I, et al. The MALT1 locus and 
peanut avoidance in the risk for peanut allergy. J Allergy Clin 
Immunol. 2019;143:2326- 2329.
 115. Krempski JW, Dant C, Nadeau K. The origins of allergy from a sys-
tems approach. Ann Allergy Asthma Immunol. 2020;125:507- 516.
 116. Nibbering B, Ubags NDJ. Microbial interactions in the atopic 
march. Clin Exp Immunol. 2020;199:12- 23.
 117. Weisser WW, Roscher C, Meyer ST, et al. Biodiversity effects on 
ecosystem functioning in a 15- year grassland experiment: patterns, 
mechanisms, and open questions. Basic Appl Ecol. 2017;23:1- 73.
 118. van der Plas F. Biodiversity and ecosystem functioning in naturally 
assembled communities. Biol Rev. 2019;94:1220- 1245.
 119. Duffy JE, Godwin CM, Cardinale BJ. Biodiversity effects in the 
wild are common and as strong as key drivers of productivity. 
Nature. 2017;549:261- 264.
 120. Dainese M, Martin EA, Aizen MA, et al. A global synthesis re-
veals biodiversity- mediated benefits for crop production. Sci Adv. 
2019;5:1- 13.
 121. Rook G, Bäckhed F, Levin BR, McFall- Ngai MJ, McLean AR. 
Evolution, human- microbe interactions, and life history plasticity. 
Lancet. 2017;390:521- 530.
 122. Moore MN. Do airborne biogenic chemicals interact with the 
PI3K/Akt/mTOR cell signalling pathway to benefit human health 
and wellbeing in rural and coastal environments? Environ Res. 
2015;140:65- 75.
 123. Antonelli M, Donelli D, Barbieri G, Valussi M, Maggini V, Firenzuoli 
F. Forest volatile organic compounds and their effects on human 
health: a state- of- the- art review. Int J Environ Res Public Health. 
2020;17:6506.
 124. Renz H, Holt PG, Inouye M, Logan AC, Prescott SL, Sly PD. An ex-
posome perspective: early- life events and immune development in 
a changing world. J Allergy Clin Immunol. 2017;140:24- 40.
 125. von Mutius E, Vercelli D. Farm living: effects on childhood asthma 
and allergy. Nat Rev Immunol. 2010;10:861- 868.
 126. Gensollen T, Lyer SS, Kasper DL, Blumberg RS. How colonization 
by microbiota in early life shapes the immune system. Science. 
2016;352:539- 544.
 127. Akdis C. Does the epithelial barrier hypothesis explain the increase 
in allergy, autoimmunity and other chronic conditions? Nat Rev 
Immunol. 2021. https://doi.org/10.1038/s4157 7- 021- 00538 - 7
 128. Ran J, MacGillivray BH, Gong Y, Hales TC. The application of 
frameworks for measuring social vulnerability and resilience to 
geophysical hazards within developing countries: a systematic re-
view and narrative synthesis. Sci Total Environ. 2020;711:134486.
 129. Haahtela T, Anto JM, Bousquet J. Fast and slow crises of Homo ur-
banicus: loss of resilience in communicable diseases, like COVID- 19, 
and non- communicable diseases. Porto Biomed J. 2020;5:4.
 130. Haahtela T, Holgate ST, Pawankar R, et al. The biodiversity hy-
pothesis and allergic disease: world allergy organization position 
statement. WAO J. 2013;6:3.
 131. von MutiusE SHH. Primary prevention of asthma: from risk and 
protective factors to targeted strategies for prevention. Lancet. 
2020;396:854- 866.
14  |    HAAHTELA ET AL.
 132. Cevhertas L, Ogular I, Maurer DJ, et al. Advances and recent de-
velopments in asthma. Allergy. 2020;75:3124- 3146.
 133. Silva TS, Hageman E, Davis JA, et al. Introducing the ORIGIN proj-
ect: a community- based interventional birth cohort. Rev Environ 
Health. 2020;45:281- 293.
 134. Bousquet J, Anto JM, Bachert C, et al. ARIA digital anamorphosis: 
digital transformation of health and care in airway diseases from 
research to practice. Allergy. 2021;76:168- 190.
 135. Trikamjee T, Comberiati P, D'Auria E, Peroni D, Zuccotti GV. 
Nutritional factors in the prevention of atopic dermatitis in chil-
dren. Front Pediatr. 2021;8:577413.
 136. Korhonen L, Oikarinen S, Lehtonen J, et al. Rhinoviruses in in-
fancy and risk of immunoglobulin E sensitization. J Med Virol. 
2019;91:1470- 1478.
 137. Nurminen N, Cerrone D, Lehtonen J, et al. Land cover of early life 
environment modulates the risk of type 1 diabetes. Diabetes Care. 
2021. https://doi.org/10.2337/dc20- 1719. [Epub ahead of print].
 138. Haahtela T, von Hertzen L, Anto JM, et al. Helsinki by nature: the 
nature step to respiratory health. Clin Transl Allergy. 2019;9:57.
 139. Halonen JI, Erhola M, Furman E, et al. A call for urgent action to 
safeguard our planet and our health in line with the Helsinki decla-
ration. Environ Res. 2021;193:110600.
 140. European Commission. Environment. European Green Capital (eu-
ropa.eu) 2021.
 141. Whitmee S, Haines A, Beyrer C, et al. Safeguarding human health in 
the anthropocene epoch: report of the Rockefeller foundation- lancet 
commission on planetary health. Lancet. 2015;386:1973- 2028.
 142. WHO. Strengthening resilience: a priority shared by health 2020 and 
the sustainable development goals. Copenhagen, Denmark: WHO 
Regional Office for Europe; 2017.
 143. Costanza R, de Groot R, Sutton P, et al. Changes in the 
global value of ecosystem services. Global Environ Change. 
2014;26:152- 158.
 144. The World Economic Forum. Nature risk rising: why the crisis 
engulfing nature matters for business and the economy 2020. 
https://www.wefor um.org/repor ts/. Accessed February 3, 2021.
 145. Seidl A, Mulungu K, Arlaud M, van den Heuvel O, Riva M. Finance 
for nature: a global estimate of public biodiversity investments. 
Ecosyst Serv. 2020;46:101216.
 146. Dasgupta P. The economics of biodiversity: the dasgupta review. 
London, UK: HM Treasury; 2021.
 147. Jantunen J, Kauppi P, Linna M, Mäkelä M, Pelkonen A, Haahtela 
T. Astman ja allergian kustannusten myönteinen kehitys jatkui 
(Positive trend in asthma and allergy costs continues). Finn Med J. 
2021;76:29- 37.(in Finnish, Abstract in English)
How to cite this article: Haahtela T, Alenius H, Lehtimäki J, et al. 
Immunological resilience and biodiversity for prevention of 
allergic diseases and asthma. Allergy. 2021;00:1–14. https://doi.
org/10.1111/all.14895
